Katie Tinkler Beats Lupus
An experimental treatment that resets a malfunctioning immune system has put the disease lupus into remission in early UK trials. Katie Tinkler, one of the first patients, said she had 'never been this good' since being diagnosed 30 years ago. She once struggled to walk with her children, but can now ski and is off all lupus medication.
- Experimental treatment resets immune system
- Lupus in remission in early UK trials
- 50,000 people affected in the UK
- mostly women
- Katie Tinkler off all medication
An experimental treatment that resets a malfunctioning immune system has put the disease lupus into remission in early UK trials. Katie Tinkler, one of the first patients, said she had 'never been this good' since being diagnosed 30 years ago. She once struggled to walk with her children, but can now ski and is off all lupus medication.
The disease, which affects around 50,000 in the UK, sees the immune system attack the body. Women make up 90% of people with lupus in the UK.
Officials said the approach could potentially treat similar disorders including multiple sclerosis and rheumatoid arthritis.
The therapy shows promise for other autoimmune diseases.
Expert Views on the Treatment
Dr Claire Roddie, from UCL, told officials that 'We're really excited about the potential of CAR-T cell therapy for autoimmune diseases. Multiple sclerosis would be one condition, we've got a clinical study running right now, and rheumatoid arthritis, for instance, huge number of patients affected by this disorder... huge potential.'
Meanwhile, sources confirmed that the treatment has been successful in putting lupus into remission in early UK trials.
Government sources said the approach could potentially treat similar disorders including multiple sclerosis and rheumatoid arthritis.
Witnesses said Katie Tinkler is one of the first patients to benefit from the treatment.
Human Impact of the Treatment
Katie Tinkler, a 30-year lupus survivor, said she had 'never been this good' since being diagnosed.
She once struggled to walk with her children, but can now ski and is off all lupus medication.
The treatment has given her a new lease on life, and she is now able to enjoy activities she thought she would never be able to do again.
Experts said the treatment has the potential to improve the lives of thousands of people affected by lupus and other autoimmune diseases.
Context of the Disease
Lupus is a chronic autoimmune disease that affects around 50,000 people in the UK.
The disease sees the immune system attack the body, causing a range of symptoms including joint pain, fatigue, and skin rashes.
Women make up 90% of people with lupus in the UK, and the disease can have a significant impact on their quality of life.
Historically, lupus has been difficult to treat, but the new experimental treatment offers hope for patients.
Future of the Treatment
The experimental treatment has shown promise in early UK trials, and officials are hopeful that it could be used to treat other autoimmune diseases.
Sources confirmed that the treatment is still in the early stages of development, but the results so far have been encouraging.
Government sources said that the treatment has the potential to improve the lives of thousands of people affected by lupus and other autoimmune diseases.
The treatment is expected to undergo further trials in the coming months.
📖 Read Full Article on NewsPulse →